UFP Technologies, Inc. (UFPT)

NASDAQ • Healthcare

$295.77

-$1.55 (-0.5%)

Market open

Last close at October 23, 2026 at 20:00 UTC

Open$295

Previous Close$295.78

Day Range$289.09 - $296.91

Avg. Volume (3M)109.5K

Market Cap$2.2B

P/E Ratio31.6

52 Week Range

$173.86$338.71

Next EarningsIn 8 daysNov 2, 2026

Metrics Over Time

Where the Money Goes

Q2 2026

Revenueeverything earned$173.9M100%

Gross Profitminus cost of goods$50.9M29%

Operating Incomeminus R&D and overhead$28M16%

Net Incomeminus taxes and the rest$20.8M12%

In plain terms: out of every $100 in revenue, UFP Technologies, Inc. keeps $12 as net profit.

Fundamentals & Financials

Revenue (TTM)

$631.6M

Net Income (TTM)

$72.2M

EPS (TTM)

$9.36

ROA (TTM)

10.6%

Current Ratio

Dividend Yield

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings

+9.2%Q3 2025$2.5

+7.7%Q4 2025$2.39

+8.0%Q1 2026$2.44

+4.1%Q2 2026$2.27

+16.5%Q3 2026$2.69

Nov 2

in 8 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026

Beat +16.5%

UFP Technologies beat expectations on both the top and bottom line in the second fiscal quarter of 2026, reported August 3, 2026, as revenue of $174.0 million topped the $159.4 million estimate (+9.1%) and EPS of $2.69 topped the $2.31 estimate (+16.5%). Revenue rose ~15% to roughly $174.0 million (up from about $151.2 million a year ago), reflecting growth in its specialty medical-device components, subassemblies, finished products, and packaging offerings. Profitability held up alongside the higher sales base, with gross profit of about $50.9 million translating to a gross margin near 29%, while operating income of roughly $28.1 million put operating margin around 16%. Net income increased ~21% to about $20.9 million (up from roughly $17.2 million a year ago), and operating cash flow came in at around $15.6 million. For the next period, consensus calls for EPS of $2.63 on revenue of $166.9 million.

Next report — what to expect

UFP Technologies, Inc. (UFPT) reports next on November 2, 2026. Wall Street is looking for consensus EPS of $2.63 on consensus revenue of $166.9 million. For trailing context, revenue grew +15.1% year over year last quarter. UFPT has beaten EPS in 8 of 8 most recent quarters.

View full earnings history

About UFP Technologies, Inc.

UFP Technologies, Inc. makes specialty products for the medical device market, using advanced foams, films, and plastics to produce components, subassemblies, finished products, packaging, and other engineered items. Listed on the NASDAQ as UFPT, the company operates in healthcare and generated $602.8 million of revenue in FY2025.

Name

UFP Technologies, Inc.

CEO

Mitchell C. Rock

Website

www.ufpt.com

Industry

Healthcare

Year Founded

1963

Employees

4,846

Today's Snapshot

AI-generated

UFPT closed 0.5% lower at 295.78, in line with a weaker sector. Earnings are due from UFPT on 2 November.

Trading Volume

Above 10d avg 105.6K

112.1K

vs S&P 500 Today

Inline with Market

+0.00%

Updated: October 23, 2026 at 20:23 UTC

Technical Indicators

5 Buy3 Neutral0 Sell

UFPT shows a generally constructive technical picture led by price sitting above short, medium and long moving averages and positive momentum readings. MACD is modestly positive and short-term averages track below the market while the 200-day level is well under current prices, which supports the buy stance even though ADX indicates only a modest trend. Volatility is moderate and the pivot is close to the session price, while on-balance volume is softer, introducing some caution. Technical takeaway: Overall Buy — price leadership above major moving averages with bullish momentum despite limited trend strength.

All signals